accountthe early diagnosis and treatment of Alzheimer's disease ('AD'), today announced that it has reached agreement with Eli Lilly and Company to increase the scope of its drug discovery collaboration. In addition to the financial terms from the original...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Applied NeuroSolutions Announces Increased Scope of Alzheimer's Disease Drug Discovery Collaboration With Eli Lilly and
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account